DOSSIER · 13F Holders · Q3 2026

CYTOMED THERAPEUTICS LIMITED

5 institutions still hold CYTOMED THERAPEUTICS LIMITED as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP Y1R80M106·5 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
$78K
visible holders
Holders
5
filers reporting
Concentration
41.90%
UBS Group AG #1
top holder share
AI Holders Summary · Q3 2026

5 institutions reported CYTOMED THERAPEUTICS LIMITED in Q3 2026. UBS Group AG leads at 41.9% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
UBS Group AG
CIK 0001610520
$33K39K0.00%Q3 2026
02
StoneX Group Inc.
CIK 0000913760
$24K27K0.00%Q3 2026
03
HRT FINANCIAL LP
CIK 0001475597
$21K26K0.00%Q3 2026
04
OSAIC HOLDINGS, INC.
CIK 0001677044
$17210.00%Q3 2026
05
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025